
|Articles|February 1, 2006
Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice
Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Genomic sequencing may transform newborn screening
2
Kathryn M. Stephenson, MD, MA, discusses GLP-1 RA decisions for pediatric obesity
3
AAP updates guidance on therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy
4
AAP publishes 2026 childhood and adolescent immunization schedule
5






